Glimisave MV 3.3 is a prescription medication used to manage Type 2 Diabetes by combining three active ingredients (Glimepiride, Metformin, Voglibose) to control high blood sugar levels, improve insulin sensitivity, and reduce after-meal glucose spikes, thereby preventing serious complications like kidney damage, blindness, nerve problems, and cardiovascular risks. It helps keep blood sugar stable when taken with diet and exercise and is not for Type 1 diabetes.
